{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:59:15Z","timestamp":1761764355154},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1038\/ncpuro0054","type":"journal-article","created":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T13:34:04Z","timestamp":1101994444000},"page":"78-84","source":"Crossref","is-referenced-by-count":14,"title":["Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity"],"prefix":"10.1038","volume":"1","author":[{"given":"Michelle Jo","family":"Semins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0054_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37\u201349","journal-title":"Urology"},{"key":"BFncpuro0054_CR2","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1001\/jama.1987.03390220074024","volume":"257","author":"NM Resnick","year":"1987","unstructured":"Resnick NM and Yalla SV (1987) Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA 257: 3076\u20133081","journal-title":"JAMA"},{"key":"BFncpuro0054_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMra032662","volume":"350","author":"JG Ouslander","year":"2004","unstructured":"Ouslander JG (2004) Management of overactive bladder. N Engl J Med 350: 786\u2013799","journal-title":"N Engl J Med"},{"key":"BFncpuro0054_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00042307-200307000-00004","volume":"13","author":"V Kumar","year":"2003","unstructured":"Kumar V et al. (2003) Recent developments in the management of detrusor overactivity. Curr Opin Urol 13: 285\u2013291","journal-title":"Curr Opin Urol"},{"key":"BFncpuro0054_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00003081-200203000-00020","volume":"45","author":"RP Goldberg","year":"2002","unstructured":"Goldberg RP and Sand PK (2002) Pathophysiology of the overactive bladder. Clin Obstet Gynecol 45: 182\u2013192","journal-title":"Clin Obstet Gynecol"},{"key":"BFncpuro0054_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1517\/13543784.10.1.65","volume":"10","author":"AJ Wein","year":"2001","unstructured":"Wein AJ (2001) Pharmacological agents for the treatment of urinary incontinence due to overactive bladder. Expert Opin Investig Drugs 10: 65\u201383","journal-title":"Expert Opin Investig Drugs"},{"key":"BFncpuro0054_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0163-7258(97)00038-7","volume":"75","author":"WH Turner","year":"1997","unstructured":"Turner WH and Brading AF (1997) Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment. Pharmacol Ther 75: 77\u2013110","journal-title":"Pharmacol Ther"},{"key":"BFncpuro0054_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0090-4295(02)01788-0","volume":"60","author":"JL Mostwin","year":"2002","unstructured":"Mostwin JL (2002) Pathophysiology: the varieties of bladder overactivity. Urology 60: 22\u201327","journal-title":"Urology"},{"key":"BFncpuro0054_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.urology.2003.09.008","volume":"62","author":"AJ Wein","year":"2003","unstructured":"Wein AJ (2003) Diagnosis and treatment of the overactive bladder. Urology 62: 20\u201327","journal-title":"Urology"},{"key":"BFncpuro0054_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/00912700122010528","volume":"41","author":"A Todorova","year":"2001","unstructured":"Todorova A et al. (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41: 636\u2013644","journal-title":"J Clin Pharmacol"},{"key":"BFncpuro0054_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00191165","volume":"47","author":"A Pietzko","year":"1994","unstructured":"Pietzko A et al. (1994) Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 47: 337\u2013343","journal-title":"Eur J Clin Pharmacol"},{"key":"BFncpuro0054_CR12","unstructured":"Indevus Pharmaceuticals Inc. (online Jul 04) Sanctura trospium chloride 20 mg tablets: Prescribing Information [www.sanctura.com] (accessed 15 Aug 04)"},{"key":"BFncpuro0054_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/nau.20062","volume":"23","author":"YT Kim","year":"2004","unstructured":"Kim YT et al. (2004) New mechanisms of action of intravesical antimuscarinic agents [abstract 167]. Neurourol Urodyn 23: 387\u2013616","journal-title":"Neurourol Urodyn"},{"key":"BFncpuro0054_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.1991.03460050063021","volume":"265","author":"JA Fantl","year":"1991","unstructured":"Fantl JA et al. (1991) Efficacy of bladder training in older women with urinary incontinence. JAMA 265: 609\u2013613","journal-title":"JAMA"},{"key":"BFncpuro0054_CR15","volume-title":"Clinical Manual of Urology","author":"AJ Wein","year":"2001","unstructured":"Wein AJ and Rovner ES (2001) Voiding function and dysfunction. In Clinical Manual of Urology, 3rd edn (Eds Hanno PM et al.) New York: McGraw-Hill"},{"key":"BFncpuro0054_CR16","volume-title":"Campbell's Urology","author":"AJ Wein","year":"2002","unstructured":"Wein AJ (2002) Neuromuscular dysfunction of the lower urinary tract and its management. In Campbell's Urology, Volume 2, 8th edn (Eds Walsh PC et al.) Philadelphia: WB Saunders"},{"key":"BFncpuro0054_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1532-5415.2000.tb04692.x","volume":"48","author":"KL Burgio","year":"2000","unstructured":"Burgio KL et al. (2000) Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 48: 370\u2013374","journal-title":"J Am Geriatr Soc"},{"key":"BFncpuro0054_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.urology.2003.10.005","volume":"63","author":"KE Andersson","year":"2004","unstructured":"Andersson KE (2004) New pharmacologic targets for the treatment of the overactive bladder: an update. Urology 63: 32\u201341","journal-title":"Urology"},{"key":"BFncpuro0054_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"BFncpuro0054_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(95)11832-H","volume":"196","author":"E Lopez-Alonso","year":"1995","unstructured":"Lopez-Alonso E et al. (1995) Botulinum toxin type A inhibits Ca(2+)-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals. Neurosci Lett 196: 37\u201340","journal-title":"Neurosci Lett"},{"key":"BFncpuro0054_CR21","volume-title":"Campbell's Urology","author":"MB Chancellor","year":"2002","unstructured":"Chancellor MB and Yoshimura N (2002) Physiology and pharmacology of the bladder and urethra. In Campbell's Urology, Volume 2, 8th edn (Eds Walsh PC et al.) Philadelphia: WB Saunders"},{"key":"BFncpuro0054_CR22","first-page":"S24","volume":"6","author":"N Yoshimura","year":"2004","unstructured":"Yoshimura N and Chancellor MB (2004) Differential diagnosis and treatment of impaired bladder emptying. Rev Urol 6: S24\u2013S31","journal-title":"Rev Urol"},{"key":"BFncpuro0054_CR23","doi-asserted-by":"publisher","first-page":"R356","DOI":"10.1152\/ajpregu.00010.2003","volume":"285","author":"I Kamo","year":"2003","unstructured":"Kamo I et al. (2003) Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol 285: R356\u2013R365","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFncpuro0054_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0090-4295(79)90397-2","volume":"13","author":"JG Blaivas","year":"1979","unstructured":"Blaivas JG et al. (1979) Urodynamic evaluation as neurologic test of sacral cord function. Urology 13: 682\u2013687","journal-title":"Urology"},{"key":"BFncpuro0054_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0140-6736(92)91184-A","volume":"339","author":"MB Chancellor","year":"1992","unstructured":"Chancellor MB et al. (1992) Lyme cystitis and neurogenic bladder dysfunction. Lancet 339: 1237\u20131238","journal-title":"Lancet"},{"key":"BFncpuro0054_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1464-410X.1973.tb00043.x","volume":"45","author":"DL Jones","year":"1973","unstructured":"Jones DL and Moore T (1973) The types of neuropathic bladder dysfunction associated with prolapsed lumbar intervertebral discs. Br J Urol 45: 39\u201343","journal-title":"Br J Urol"},{"key":"BFncpuro0054_CR27","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","volume":"168","author":"N Yoshimura","year":"2002","unstructured":"Yoshimura N and Chancellor MB (2002) Current and future pharmacological treatment for overactive bladder. J Urol 168: 1897\u20131913","journal-title":"J Urol"},{"key":"BFncpuro0054_CR28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0022-5347(05)66979-0","volume":"164","author":"CR Riedl","year":"2000","unstructured":"Riedl CR et al. (2000) Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol 164: 2108\u20132111","journal-title":"J Urol"},{"key":"BFncpuro0054_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00005392-200101000-00035","volume":"165","author":"KV Carlson","year":"2001","unstructured":"Carlson KV et al. (2001) Dysfunctional voiding in women. J Urol 165: 143\u2013147","journal-title":"J Urol"},{"key":"BFncpuro0054_CR30","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI et al. (2003) Diabetic autonomic neuropathy. Diabetes Care 26: 1553\u20131579","journal-title":"Diabetes Care"},{"key":"BFncpuro0054_CR31","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0022-5347(17)42038-6","volume":"140","author":"EA Tanagho","year":"1988","unstructured":"Tanagho EA and Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140: 1331\u20131339","journal-title":"J Urol"},{"key":"BFncpuro0054_CR32","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/sj.gt.3301816","volume":"9","author":"J Huard","year":"2002","unstructured":"Huard J et al. (2002) Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 9: 1617\u20131626","journal-title":"Gene Ther"},{"key":"BFncpuro0054_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0022-5347(17)47273-9","volume":"134","author":"SA Awad","year":"1985","unstructured":"Awad SA (1985) Clinical use of bethanechol. J Urol 134: 523\u2013524","journal-title":"J Urol"},{"key":"BFncpuro0054_CR34","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW et al. (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165: 1107\u20131110","journal-title":"J Urol"},{"key":"BFncpuro0054_CR35","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/01.ju.0000085961.27403.4a","volume":"170","author":"MP Cain","year":"2003","unstructured":"Cain MP et al. (2003) Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol 170: 1514\u20131515","journal-title":"J Urol"},{"key":"BFncpuro0054_CR36","volume-title":"Smith's General Urology","author":"JC Presti","year":"2004","unstructured":"Presti JC Jr (2004) Neoplasms of the prostate gland. In Smith's General Urology, 16th edn (Eds Tanagho EA and McAninch JW) New York: Lange Medical Books\/McGraw-Hill"},{"key":"BFncpuro0054_CR37","first-page":"61","volume":"4","author":"CP Smith","year":"2002","unstructured":"Smith CP et al. (2002) Botulinum toxin: poisoning the spastic bladder and urethra. Rev Urol 4: 61\u201368","journal-title":"Rev Urol"},{"key":"BFncpuro0054_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11934-003-0041-z","volume":"4","author":"BP Duel","year":"2003","unstructured":"Duel BP (2003) Biofeedback therapy and dysfunctional voiding in children. Curr Urol Rep 4: 142\u2013145","journal-title":"Curr Urol Rep"},{"key":"BFncpuro0054_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0090-4295(02)02541-4","volume":"61","author":"HC Kuo","year":"2003","unstructured":"Kuo HC (2003) Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology 61: 550\u2013554","journal-title":"Urology"},{"key":"BFncpuro0054_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1471-4914(01)02088-3","volume":"7","author":"MB Chancellor","year":"2001","unstructured":"Chancellor MB et al. (2001) Gene therapy strategies for urological dysfunction. Trends Mol Med 7: 301\u2013306","journal-title":"Trends Mol Med"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0054","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:19:29Z","timestamp":1684444769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BFncpuro0054"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0054","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}